Country Lead, Flow Neuroscience
Germany
+ Share options
Wearable home treatment for depression
Be an early applicant
Wearable home treatment for depression
21-100 employees
Be an early applicant
+ Share options
21-100 employees
Company mission
To find new ways of treating mental health issues, using science and technology.
Role
Who you are
- Experience growing an early stage business in Germany, or taking an existing business and launching it into the German market
- Growth mindset - ability to continually learn, stay resilient when things aren’t going your way and spot new opportunities
- Fluent in German
- Self motivated and incredibly autonomous - you’ll be working independently to grow this market
- Analytical - you test and measure your ideas in a structured way
- Entrepreneurial - we want people who will treat Flow like their own business
- You want to work for a small company of exceptional people with big ambitions
What the job involves
- We’re looking for a data driven, highly autonomous, entrepreneurial growth expert
- Reporting directly to the Chief Growth Officer, you’ll be taking a market in its infancy, testing the UK playbook, using your understanding of the local market to adapt the pricing, partnerships, messaging and marketing channels to fit the cultural nuances of the German market
- Scale digital marketing spend in Germany
- Drive improvements in website conversion rate
- Build a community of Flow users willing to contribute case studies for media coverage, website and ads
- Identify, win and manage partnerships in Germany to increase trust in the brand
- Manage inbound sales process for clinicians, pharmacies and distributors
- Build playbook for winning German media coverage
- Support with future hiring of German-native speakers to support Flow expansion in Germany
- Note: you will have specialist support from the UK team in technical areas where you need it, i.e. operating digital marketing platforms, PR etc. You will also have dev resource for CRO program.)
Our take
Despite the prevalence of mental health conditions such as anxiety and depression, medicine has been relatively slow to respond with new treatment options. Particularly, at-home treatment has been limited to medication, or more recently virtual talk therapy. Flow Neuroscience has developed a wearable tDCS (transcranial Direct Current Stimulation) device for patients to use at home, with a complementary app to help manage the symptoms of major depressive disorder.
Flow’s treatment, the first of its kind approved for home use in Europe, allows users to administer tCDS without a doctor and away from a clinical setting. The company has been committed to following the rigorous medical research and testing framework, with the device undergoing early trials in the UK and EU, which have so far received positive results from users.
In 2022, Flow Neuroscience collaborated with Curebase to launch a large-scale FDA-approved clinical trial of its product. Off the back of this trial, the company entered the MedTech Innovator support programme in 2023. It will also seek FDA approval for its headset, which if successful will open the door for client reach expansion across the UK, EU, and US.
Kirsty
Company Specialist at Welcome to the Jungle
Insights
Company
Funding (last 2 of 3 rounds)
Aug 2021
$8.9m
SERIES A
Jul 2019
$1.4m
EARLY VC
Total funding: $11.4m
Company benefits
- Remote & hybrid options
- Flexible working hours
- Be part of a small team scaling a cutting-edge product that could change the way the world thinks about mental health treatment
Company HQ
Gamla staden, Malmö, Skåne County
Articles
Leadership
Daniel Månsson
(Chief Clinical Officer)Former CEO of the company. Previously a Clinical Psychologist at Østfold Hospital Trust.
Erik M. Rehn
(CTO)Co-Founder and Board Member at Slagkryssaren. Co-Founder and former VP at Stockholm.AI.
Share this job